肝胆相照论坛

标题: AASLD2019[a271]CXCR5表达CD8 + T细胞有助于HBsAg 慢性HBV感染的清除 [打印本页]

作者: StephenW    时间: 2019-10-25 17:41     标题: AASLD2019[a271]CXCR5表达CD8 + T细胞有助于HBsAg 慢性HBV感染的清除

a 271
CXCR5-EXPRESSING CD8+ T CELLS CONTRIBUTE TO HBsAg
CLEARANCE IN CHRONIC HBV INFECTION
Yongyin Li, Libo Tang, Chengcong Chen, Shuqin Gu, Yang
Zhou, Guofu Ye, Xiaoyi Li, Weibin Wang, Jian Sun, Jie Peng
and Jinlin Hou, Department of Infectious Diseases , Nanfang
Hospital, Southern Medical University
Background: CD8+ T cell dysfunction impairs immunemediated
viral control in chronic hepatitis B virus (HBV)
infection, however, the pool of CD8+ T cells is functionally
heterogeneous Therefore, CD8+ T cell subpopulations with
unique properties, particularly those with defining functions,
should be further investigated This study aims to dissect a
subset of CD8+ T cells expressing C-X-C motif chemokine
receptor 5 (CXCR5) in chronic HBV infection. Methods:
The frequency of circulating CXCR5+CD8+ T cells and the
levels of C-X-C motif chemokine ligand 13 (CXCL13) were
measured in chronic hepatitis B (CHB) patients receiving
nucleos(t)ide analogue antiviral therapy A series of surface
markers of peripheral and hepatic CXCR5+ and CXCR5−
CD8+ T cells were assessed, as well as the expression of
intracellular HBV-specific interferon (IFN)-γ or interleukin (IL)-
21. Immunocompetent C57BL/6, IL-21 receptor-deficient or
μMT mice (B cell-deficient) were hydrodynamically injected
with pAAV-HBV1.2 plasmids. Some of the mice were given
an injection of sorted CXCR5+CD8+ or CXCR5−CD8+ T cells
Serum levels of hepatitis B surface antigen (HBsAg) and the
frequency of HBV-specific IFN-γ from peripheral, splenic,
and hepatic CXCR5+CD8+ T cells were assessed Results:
CXCR5+CD8+ T cells were expanded and possessed
distinctive phenotypical and transcriptional properties in
patients with chronic HBV infection (Figure A); moreover,
this subset of CD8+ T cells maintained decent antiviral ability
and was associated with favorable treatment response in
CHB patients (Figure B-D) Although CXCR5+CD8+ T cells
showed higher expression of programmed cell death 1
(PD1) than that of the CXCR5− subset, they demonstrated
a status of activation with memory potential based on their
enhanced expression of CD69 and CD38 as well as CD62L
and CCR7 (Figure E) Notably, high levels of CXCL13 from
patients with HBV infection promoted the recruitment of
intrahepatic CXCR5+CD8+ T cells and were associated with
favorable outcomes (Figure F), and an increased production
of HBV-specific IFN-γ and IL-21 was found in intrahepatic
CXCR5+CD8+ T cells (Figure G and H) More strikingly, mice
with adoptive transfer of CXCR5+CD8+ T cells exhibited a more
potent ability to control HBV replication (Figure I). Additionally,
an impaired production of HBV-specific IFN-γ from hepatic
CXCR5+CD8+ T cells was observed in mice deficient in IL-
21 receptor or in B cells (Figure J and K). Conclusion:
CXCR5+CD8+ T cells demonstrate potent anti-HBV effect
and facilitate HBsAg clearance in chronic HBV infection. The
identification of this unique subpopulation may contribute to
a better understanding of CD8+ T cell functions and provide a
potential immunotherapeutic target for HBV cure.
作者: StephenW    时间: 2019-10-25 17:42

一个271
CXCR5表达CD8 + T细胞有助于HBsAg
慢性HBV感染的清除
李永银,唐立波,陈承聪,顾树芹,杨
周国烨,叶小怡,王伟斌,孙健,彭杰
南方医院传染病科侯锦林
南方医科大学附属医院
背景:CD8 + T细胞功能障碍损害免疫介导
慢性乙型肝炎病毒(HBV)的病毒控制
感染,但是CD8 + T细胞池在功能上
因此,CD8 + T细胞亚群具有
独特的属性,尤其是具有定义功能的属性,
应该进一步研究该研究旨在剖析
表达C-X-C基序趋化因子的CD8 + T细胞的一部分
慢性HBV感染中的受体5(CXCR5)。方法:
循环CXCR5 + CD8 + T细胞的频率和
C-X-C基序趋化因子配体13(CXCL13)的水平为
接受慢性乙型肝炎(CHB)的患者的测量
核苷酸(t)ide类似物抗病毒治疗一系列表面
和肝CXCR5 +和CXCR5-的标记
评估CD8 + T细胞以及CD8 + T细胞的表达
细胞内HBV特异性干扰素(IFN)-γ或白介素(IL)-
21.免疫活性C57BL / 6,IL-21受体缺陷或
μMT小鼠(B细胞缺陷)被水动力注射
pAAV-HBV1.2质粒。给了一些老鼠
注射分选的CXCR5 + CD8 +或CXCR5-CD8 + T细胞
血清乙型肝炎表面抗原(HBsAg)和
外周血,脾脏,HBV特异性IFN-γ的频率
和肝CXCR5 + CD8 + T细胞进行了评估。结果:
CXCR5 + CD8 + T细胞被扩增并拥有
独特的表型和转录特性
慢性HBV感染患者(图A);此外,
CD8 + T细胞的这一亚群保持了良好的抗病毒能力
并与良好的治疗反应有关
CHB患者(图B-D)尽管CXCR5 + CD8 + T细胞
显示较高的程序性细胞死亡表达1
(PD1)高于CXCR5-子集
基于它们的记忆潜力的激活状态
CD69和CD38以及CD62L的增强表达
和CCR7(图E)值得注意的是,高水平的CXCL13来自
HBV感染患者促进了
肝内CXCR5 + CD8 + T细胞并与
有利的结果(图F),产量增加
肝内发现HBV特异性IFN-γ和IL-21的表达
CXCR5 + CD8 + T细胞(图G和H)更令人惊讶的是,小鼠
过继转移CXCR5 + CD8 + T细胞表现出更多
控制HBV复制的有效能力(图I)。另外,
肝产生的HBV特异性IFN-γ受损
在IL-缺乏的小鼠中观察到CXCR5 + CD8 + T细胞
21受体或在B细胞中(图J和K)。结论:
CXCR5 + CD8 + T细胞显示有效的抗HBV效应
并促进慢性HBV感染中HBsAg的清除。的
识别这种独特的亚群可能有助于
更好地了解CD8 + T细胞功能并提供
潜在的HBV免疫治疗靶标。




欢迎光临 肝胆相照论坛 (http://hbvhbv.info/forum/) Powered by Discuz! X1.5